Impact of immune-related adverse events on survival outcomes in extensive-stage small cell lung cancer patients treated with immune checkpoint inhibitors.
Tadashi NishimuraHajime FujimotoTakumi FujiwaraKentaro ItoAtsushi FujiwaraHisamichi YudaHidetoshi ItaniMasahiro NaitoShuji KodamaKazuki FuruhashiAkihiko YagiHaruko SaikiTaro YasumaTomohito OkanoAtsushi TomaruMotoaki TanigawaMasamichi YoshidaOsamu HatajiHidenori IbataCorina N D'Alessandro-GabazzaEsteban C GabazzaTetsu KobayashiPublished in: Cancer medicine (2024)
The results of this study show that immune-related adverse events are associated with improved survival outcomes in patients with extensive-stage small cell lung cancer.
Keyphrases